Advertisement

Nuclea Biotechnologies LLC, a cancer diagnostics firm in Pittsfield, has rounded up $3 million in an equity offering backed by 28 investors, the company noted in a regulatory filing today.

The filing with the U.S. Securities and Exchange Commission did not disclose the names of the investors.

SOURCE

Advertisement
Advertisement